🟢 20/20 Biolabs is trading 7.1% up in pre-market

20/20 Biolabs is trading 7.1% higher at $0.38 in pre-market, with the reason for the gain still uncertain.

• On October 2, the company announced that its CEO and CFO would attend the Maxim Growth Summit, with investor meetings scheduled for October 13–14. This was previously announced, scheduled news.
• Broader market indicators were mixed and do not clearly explain the gain.